TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
This report contains market size and forecasts of Anti-fungal Drugs in Global, including the following market information:
Global top five companies in 2021 (%)
The global Anti-fungal Drugs market was valued at 1770.4 million in 2021 and is projected to reach US$ 2075.4 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-fungal Drugs include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-fungal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-fungal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-fungal Drugs Market Segment Percentages, by Type, 2021 (%)
| Report Attributes | Report Details |
|---|---|
| Report Title | Anti-fungal Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 67 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
